TxCell Receives EU Orphan Drug Designation for Col-Treg

News   Dec 19, 2014

 
TxCell Receives EU Orphan Drug Designation for Col-Treg
 
 
 

RELATED ARTICLES

Discovery Provides Hope for New Vaccine Against Flesh-eating Bacteria

News

Researchers at Houston Methodist have solved a 100-year-old mystery, providing them a possible key to unlock a pathway for treating diseases caused by flesh-eating bacteria.

READ MORE

Cancer-fighting Cells Get a Boost from Oxygen Starvation Treatment

News

Mountain climbers and endurance athletes are not the only ones to benefit from altitude training – that is, learning to perform well under low-oxygen conditions.

READ MORE

Hits for a Novel Drug Target Identified for Depression and Pain

News

Novel small molecules have been identified that might be transformed into a new medical treatment of depression and/or even the potential in the treatment of pain.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE